Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa

作者: LV Rao , SI Rapaport

DOI: 10.1182/BLOOD.V75.5.1069.1069

关键词: EndocrinologyFactor XIn vivoHemostasisFactor VIIInternal medicineCoagulationThromboplastinChemistryFactor IXaTissue factor

摘要: Infusing factor VIIa (FVIIa) has been reported to control bleeding in hemophilic patients with VIII (FVIII) inhibitors. This is difficult attribute an enhanced FVIIa/tissue (TF) activation of X, since vitro studies suggest that infusion FVIIa should neither increase substantially the rate formation FVIIa/TF complexes during hemostasis (Proc Natl Acad Sci USA 85:6687, 1988) nor bypass dampening TF-dependent coagulation by extrinsic pathway inhibitor (EPI) (Blood 73:359, 1989). Partial thromboplastin times have also shorten after FVIIa. The experiments herein establish shortening partial adding plasma stems from FVIIa-catalyzed X independent possible trace contamination reagents TF. Experiments purified systems confirmed can slowly activate a reaction mixture containing Ca2+ and phospholipid but no source was sufficient account for observed. EPI, which turned off continuing unable prevent FVIIa/phospholipid X. Because circulating contains only trace, if any, free FVIIa, such could never occur physiologically. However, infusing creates nonphysiologic circumstance slow catalyzed conceivably proceed vivo unimpeded EPI. Such mechanism might compensate impaired IXa/FVIIIa/phospholipid hemostatis, therefore patient.

参考文章(21)
Y Nemerson, Tissue factor and hemostasis Blood. ,vol. 71, pp. 1- 8 ,(1988) , 10.1182/BLOOD.V71.1.1.BLOODJOURNAL7111
BC Miller, MB Hultin, J Jesty, Altered factor VII activity in hemophilia. Blood. ,vol. 65, pp. 845- 849 ,(1985) , 10.1182/BLOOD.V65.4.845.845
LV Rao, SP Bajaj, SI Rapaport, Activation of human factor VII during clotting in vitro. Blood. ,vol. 65, pp. 218- 226 ,(1985) , 10.1182/BLOOD.V65.1.218.218
S. Paul Bajaj, Samuel I. Rapaport, Christina Prodanos, A Simplified Procedure for Purification of Human Prothrombin, Factor IX and Factor X Preparative Biochemistry & Biotechnology. ,vol. 11, pp. 397- 412 ,(1981) , 10.1080/00327488108065531
U Hedner, W Kisiel, Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. Journal of Clinical Investigation. ,vol. 71, pp. 1836- 1841 ,(1983) , 10.1172/JCI110939